Subsequently, Roberta et al. tried to inject ASC-Exo into ALS mice transgenic for SOD1 (G93A) and found that this treatment significantly improved motor performance, protected lumbar motor neurons, neuromuscular junctions and muscles in ALS mice (Bonafede et al., 2020). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.